Transient visual anomalies associated with drug treatment for spastic colon.
A case report revealing two previously unreported adverse side effects of meprobamate and tridihexethyl chloride (Milpath) drug therapy for a spastic colon is presented. The two previously unreported adverse effects are a diffuse loss of color discrimination and an increased time course to complete dark adaptation.
D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D003117:Color Vision Defects / Q000139:chemically induced; D005260:Female; D006801:Humans; D008620:Meprobamate / Q000009:adverse effects*; D008875:Middle Aged; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects*; D013997:Time Factors; D014786:Vision Disorders / Q000139:chemically induced* / Q000503:physiopathology; D014792:Visual Acuity / Q000187:drug effects
D000644:Quaternary Ammonium Compounds; C005386:tridihexethyl; D008620:Meprobamate